文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

机械通气合并循环休克患者早期与延迟肠内营养:一项国际多中心实用性临床试验的巢式队列分析

Early versus delayed enteral nutrition in mechanically ventilated patients with circulatory shock: a nested cohort analysis of an international multicenter, pragmatic clinical trial.
PubMed 文献 · Crit Care · 2022-06-09
一句话结论机械通气合并循环休克患者中,早期肠内营养(<48 h)与改善的临床结局相关,但校正疾病严重程度后关联不再存在,需RCT验证。

本研究为一项国际多中心实用性随机临床试验的巢式队列分析,纳入14个国家52个ICU的626例机械通气合并循环休克患者,早期肠内营养定义为入ICU<48 h启动,延迟为>48 h。早期肠内营养组28天持续器官功能障碍综合征+死亡为42%,延迟组为53%(p=0.04);早期组无ICU天数更多(9.3±9.2 vs 5.7±7.9,p=0.0002),存活且无血管加压药天数更多(7.1±3.1 vs 6.3±3.2,p=0.007),存活者机械通气时间更短(9.8±10.9 vs 13.8±14.5,p=0.0002)。校正年龄、mNUTRIC评分、APACHE II评分、脓毒症和中心后,上述趋势不再存在;两组ICU/60天死亡率或喂养不耐受率无差异。作者认为需开展RCT比较早期与延迟肠内营养的疗效。

要点

  • 626例机械通气合并循环休克患者中,早期肠内营养(<48 h)组28天持续器官功能障碍综合征+死亡为42%,延迟组(>48 h)为53%(p=0.04)。
  • 早期肠内营养组无ICU天数更多(9.3±9.2 vs 5.7±7.9,p=0.0002),存活且无血管加压药天数更多(7.1±3.1 vs 6.3±3.2,p=0.007)。
  • 存活者中早期肠内营养组机械通气时间更短(9.8±10.9 vs 13.8±14.5,p=0.0002)。
  • 校正年龄、mNUTRIC评分、APACHE II评分、脓毒症和中心后,早期肠内营养与临床结局的关联不再存在。
  • 两组ICU/60天死亡率和喂养不耐受率无差异;作者认为需RCT比较早期与延迟肠内营养的疗效。

适用人群与场景

  • 机械通气合并循环休克的ICU患者,来自14个国家52个ICU。
  • 中位年龄60岁[18-93],55%为脓毒性休克,99%单用去甲肾上腺素,91%单用肠内营养,50.3%被随机分配至常规蛋白剂量。

诊断标准与关键阈值

  • 早期肠内营养(EEN)定义为入ICU<48 h启动肠内营养;延迟肠内营养(DEN)定义为入ICU>48 h启动。

研究设计与关键结果

  • 研究类型:国际多中心实用性随机临床试验的巢式队列分析,纳入626例机械通气合并循环休克患者,来自52个ICU、14个国家。
  • 早期肠内营养组28天持续器官功能障碍综合征+死亡为42%,延迟肠内营养组为53%(p=0.04)。
  • 早期肠内营养组无ICU天数更多(9.3±9.2 vs 5.7±7.9,p=0.0002)。
  • 早期肠内营养组存活且无血管加压药天数更多(7.1±3.1 vs 6.3±3.2,p=0.007)。
  • 存活者中早期肠内营养组机械通气时间更短(9.8±10.9 vs 13.8±14.5,p=0.0002)。
  • 校正年龄、mNUTRIC评分、APACHE II评分、脓毒症和中心后,上述趋势不再存在。
  • 两组ICU/60天死亡率和喂养不耐受率无差异。

证据类型、等级与局限

  • 证据类型:国际多中心实用性随机临床试验的巢式队列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在机械通气合并循环休克患者中,早期肠内营养(<48 h)与改善的临床结局相关,但校正疾病严重程度后关联不再存在,作者认为需开展RCT比较早期与延迟肠内营养的疗效。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Real-world evidence on the timing and efficacy of enteral nutrition (EN) practices in intensive care unit (ICU) patients with circulatory shock is limited. We hypothesized early EN (EEN), as compared to delayed EN (DEN), is associated with improved clinical outcomes in mechanically ventilated (MV) patients with circulatory shock.

METHODS: We analyzed a dataset from an international, multicenter, pragmatic randomized clinical trial (RCT) evaluating protein dose in ICU patients. Data were collected from ICU admission, and EEN was defined as initiating < 48 h from ICU admission and DEN > 48 h. We identified MV patients in circulatory shock to evaluate the association between the timing of EN initiation and clinical outcomes. The regression analysis model controlled for age, mNUTRIC score, APACHE II score, sepsis, and Site.

RESULTS: We included 626 patients, from 52 ICUs in 14 countries. Median age was 60 years [18-93], 55% had septic shock, 99% received norepinephrine alone, 91% received EN alone, and 50.3% were randomized to a usual protein dose. Forty-two percent of EEN patients had persistent organ dysfunction syndrome plus death at day 28, compared to 53% in the DEN group (p = 0.04). EEN was associated with more ICU-free days (9.3 ± 9.2 vs. 5.7 ± 7.9, p = 0.0002), more days alive and free of vasopressors (7.1 ± 3.1 vs. 6.3 ± 3.2, p = 0.007), and shorter duration of MV among survivors (9.8 ± 10.9 vs. 13.8 ± 14.5, p = 0.0002). This trend was no longer observed in the adjusted analysis. There were no differences in ICU/60-day mortality or feeding intolerance rates between groups.

CONCLUSION: In MV patients with circulatory shock, EEN, as compared to DEN, was associated with improved clinical outcomes, but no longer when adjusting for illness severity. RCTs comparing the efficacy of EEN to DEN in MV patients with circulatory shock are warranted.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Ortiz-Reyes L, Patel JJ, Jiang X, et al. Early versus delayed enteral nutrition in mechanically ventilated patients with circulatory shock: a nested cohort analysis of an international multicenter, pragmatic clinical trial. Crit Care. 2022. PMID: 35681220. doi:10.1186/s13054-022-04047-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。